BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12000306)

  • 1. Synthesis of cryptophycin 52 using the Shi epoxidation.
    Hoard DW; Moher ED; Martinelli MJ; Norman BH
    Org Lett; 2002 May; 4(10):1813-5. PubMed ID: 12000306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of cryptophycin 52 using the sharpless asymmetric dihydroxylation: diol to epoxide transformation optimized for a base-sensitive substrate.
    Liang J; Moher ED; Moore RE; Hoard DW
    J Org Chem; 2000 May; 65(10):3143-7. PubMed ID: 10814209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel cryptophycin antitumor agents: synthesis and cytotoxicity of fragment "B" analogues.
    Patel VF; Andis SL; Kennedy JH; Ray JE; Schultz RM
    J Med Chem; 1999 Jul; 42(14):2588-603. PubMed ID: 10411479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A convergent approach to cryptophycin 52 analogues: synthesis and biological evaluation of a novel series of fragment a epoxides and chlorohydrins.
    Al-Awar RS; Ray JE; Schultz RM; Andis SL; Kennedy JH; Moore RE; Liang J; Golakoti T; Subbaraju GV; Corbett TH
    J Med Chem; 2003 Jul; 46(14):2985-3007. PubMed ID: 12825938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three new cryptophycins from Nostoc sp. GSV 224.
    Subbaraju GV; Golakoti T; Patterson GM; Moore RE
    J Nat Prod; 1997 Mar; 60(3):302-5. PubMed ID: 9090872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enantioselective synthesis of (+)-cryptophycin 52 (LY355703), a potent antimitotic antitumor agent.
    Ghosh AK; Swanson L
    J Org Chem; 2003 Dec; 68(25):9823-6. PubMed ID: 14656116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient synthesis of cryptophycin-52 and novel para-alkoxymethyl unit A analogues.
    Eissler S; Bogner T; Nahrwold M; Sewald N
    Chemistry; 2009 Oct; 15(42):11273-87. PubMed ID: 19760734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical anticancer activity of cryptophycin-8.
    Corbett TH; Valeriote FA; Demchik L; Polin L; Panchapor C; Pugh S; White K; Knight J; Jones J; Jones L; LoRusso P; Foster B; Wiegand RA; Lisow L; Golakoti T; Heltzel CE; Ogino J; Patterson GM; Moore RE
    J Exp Ther Oncol; 1996 Mar; 1(2):95-108. PubMed ID: 9414393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryptophycins: a novel class of potent antimitotic antitumor depsipeptides.
    Shih C; Teicher BA
    Curr Pharm Des; 2001 Sep; 7(13):1259-76. PubMed ID: 11472266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro pharmacology of cryptophycin 52 (LY355703) in human tumor cell lines.
    Wagner MM; Paul DC; Shih C; Jordan MA; Wilson L; Williams DC
    Cancer Chemother Pharmacol; 1999; 43(2):115-25. PubMed ID: 9923816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of the epoxide cryptophycin analog, LY355703 to albumin and its effect on in vitro antiproliferative activity.
    Schultz RM; Shih C; Wood PG; Harrison SD; Ehlhardt WJ
    Oncol Rep; 1998; 5(5):1089-94. PubMed ID: 9683814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A convergent synthesis of (+)-cryptophycin B, a potent antitumor macrolide from Nostoc sp. cyanobacteria.
    Ghosh AK; Bischoff A
    Org Lett; 2000 Jun; 2(11):1573-5. PubMed ID: 10841482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of the antitumor compound cryptophycin-52 with tubulin.
    Panda D; Ananthnarayan V; Larson G; Shih C; Jordan MA; Wilson L
    Biochemistry; 2000 Nov; 39(46):14121-7. PubMed ID: 11087360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfinyl moiety as an internal nucleophile. 1. Efficient stereoselective synthesis of fragment a of cryptophycin 3.
    Raghavan S; Tony KA
    J Org Chem; 2003 Jun; 68(12):5002-5. PubMed ID: 12790623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereospecific synthesis of cryptophycin 1.
    Li LH; Tius MA
    Org Lett; 2002 May; 4(10):1637-40. PubMed ID: 12000261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the cryptophycin P450 epoxidase reveals substrate tolerance and cooperativity.
    Ding Y; Seufert WH; Beck ZQ; Sherman DH
    J Am Chem Soc; 2008 Apr; 130(16):5492-8. PubMed ID: 18366166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute vulvar vestibulitis occurring during chemotherapy with cryptophycin analogue LY355703.
    De Pas TM; MandalĂ  M; Curigliano G; Peccatori F
    Obstet Gynecol; 2000 Jun; 95(6 Pt 2):1030. PubMed ID: 10808018
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro effect of cryptophycin 52 on microtubule assembly and tubulin: molecular modeling of the mechanism of action of a new antimitotic drug.
    Barbier P; Gregoire C; Devred F; Sarrazin M; Peyrot V
    Biochemistry; 2001 Nov; 40(45):13510-9. PubMed ID: 11695898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-binding patterns of the antitumor antibiotic cryptophycin 52 as measured with a two-phase partitioning system.
    Kessel D
    J Chromatogr B Biomed Sci Appl; 1999 Nov; 735(1):121-6. PubMed ID: 10630897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First generation design, synthesis, and evaluation of azepine-based cryptophycin analogues.
    Smith AB; Cho YS; Zawacki LE; Hirschmann R; Pettit GR
    Org Lett; 2001 Dec; 3(25):4063-6. PubMed ID: 11735585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.